fibromuscular dysplasia

From Aaushi
Jump to navigation Jump to search

Etiology

Epidemiology

Pathology

Clinical manifestations

Laboratory

Radiology

Management

More general terms

Additional terms

References

  1. 1.0 1.1 1.2 1.3 Medical Knowledge Self Assessment Program (MKSAP) 11, 16, 19. American College of Physicians, Philadelphia 1998, 2012, 2021
  2. Mayo Internal Medicine Board Review, 1998-99, Prakash UBS (ed) Lippincott-Raven, Philadelphia, 1998, pg 898-99
  3. 3.0 3.1 3.2 Olin JW, Sealove BA. Diagnosis, management, and future developments of fibromuscular dysplasia. J Vasc Surg. 2011 Mar;53(3):826-36.e1 PMID: https://www.ncbi.nlm.nih.gov/pubmed/21236620
  4. 4.0 4.1 Bagh I, Olin JW, Froehlich JB et al Association of Multifocal Fibromuscular Dysplasia in Elderly Patients With a More Benign Clinical Phenotype. Data From the US Registry for Fibromuscular Dysplasia. JAMA Cardiol. Published online June 20, 2018 PMID: https://www.ncbi.nlm.nih.gov/pubmed/29926082 https://jamanetwork.com/journals/jamacardiology/fullarticle/2685210
  5. Olin JW, Gornik HL, Bacharach JM et al Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. Circulation. 2014 Mar 4;129(9):1048-78. PMID: https://www.ncbi.nlm.nih.gov/pubmed/24548843
  6. 6.0 6.1 Gornik HL, Persu A, Adlam D First International Consensus on the diagnosis and management of fibromuscular dysplasia. Vasc Med. 2019 Apr;24(2):164-189 PMID: https://www.ncbi.nlm.nih.gov/pubmed/30648921
  7. 7.0 7.1 Slovut DP, Olin JW.. Fibromuscular dysplasia N Engl J Med 2004;350:1862-71 PMID: https://www.ncbi.nlm.nih.gov/pubmed/15115832
  8. 8.0 8.1 NEJM Knowledge+